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Abstract The yeast Nha1 Na+,K+/H+ antiporter may play an
important role in regulation of cell cycle, as high-copy expres-
sion of the NHA1 gene is able to rescue the blockage at the G1/
S transition of cells lacking Sit4 protein phosphatase and Hal3
activities. Interestingly, this function was independent of the role
of the antiporter in improving tolerance to sodium cations, it
required the integrity of a relatively large region (from residues
800 to 948) of its carboxy-terminal moiety, and was not per-
formed by the ¢ssion yeast homolog antiporter Sod2, which
lacks a carboxy-terminal tail. Here we show that a hybrid pro-
tein composed of the Sod2 antiporter fused to the carboxy-ter-
minal half of Nha1 strongly increased sodium tolerance, but did
not allow growth at high potassium nor did rescue growth of the
sit4 hal3 conditional mutant strain. Deletion of Nha1 residues
from 800 to 849, 900 to 925 or 926 to 954 abolished the func-
tion of Nha1 in cell cycle without a¡ecting sodium tolerance. A
screening for loss-of-function mutations at the 775^980 car-
boxy-terminal tail of Nha1 has revealed a number of residues
required for function in cell cycle, most of them clustering in
two regions, from residues 869 to 876 (cluster A) and 918 to 927
(cluster B). The later is rather conserved in other related anti-
porters, while the former is not.
7 2003 Published by Elsevier Science B.V. on behalf of the
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1. Introduction
Naþ/Hþ antiporters are an important family of proteins
present in the membranes of most cell types, from human to
bacteria, which play a key role in maintaining cation and pH
homeostasis [1]. In yeast cells, the Naþ/Hþ antiporters serve
to remove intracellular sodium cations utilizing the external
Hþ accumulation generated by the plasma membrane Hþ-
ATPase (for a review, see [2]). A number of genes encoding
plasma membrane Naþ/Hþ antiporters have been cloned
within the last few years from di¡erent yeast species, such
as Schizosaccharomyces pombe [3], Zygosaccharomyces rouxii
[4,5], Saccharomyces cerevisiae [6] or Candida albicans [7], thus
allowing a preliminary characterization of this type of pro-
teins. As their mammalian counterparts, they are composed in
many cases by a hydrophobic, membrane-bound region, com-
prising 10^12 transmembrane domains, followed by a hydro-
philic carboxy-terminal tail. One of the few exceptions is the
S. pombe Sod2 antiporter, which contains only the transmem-
brane moiety. While the primary sequences corresponding to
the transmembrane region are rather similar, the divergence at
the carboxy-terminal tail is quite high, and only a few short
regions are conserved [8].
Naþ/Hþ antiporters from di¡erent yeast species also di¡er
in their substrate speci¢city for alkali cations: for instance,
while Sod2 transports only Naþ and Liþ, the antiporters
from S. cerevisiae (Nha1) and C. albicans (Cnh1) are able to
recognize also Kþ and Rbþ as substrates. In the case of the
budding yeast S. cerevisiae, Nha1 has only a modest role in
mediating sodium tolerance, particularly at moderately acidic
and neutral pH [6,9]. Nha1 has been proposed to regulate
intracellular pH [9,10], to mediate sodium and potassium ef-
£ux [9], and to promote growth at low Kþ concentrations,
probably through regulation of Trk1-dependent Kþ uptake
[11].
The budding yeast Ser/Thr phosphatases Sit4 and Ppz1 are
positive and negative e¡ectors, respectively, of the G1/S tran-
sition at the cell cycle [12^14]. HAL3 encodes a negative reg-
ulator of Ppz1 [15] and, consequently, a sit4 hal3 mutant
cannot grow because of a severe blockage in G1/S [16^18].
In a recent paper [18], we described the construction of a
conditional sit4 hal3 mutant strain (JC002) and its use to
carry out a high-copy screening for suppressors of the sit4
hal3 synthetically lethal phenotype. This screening yielded,
among other genes, the NHA1 antiporter gene, pointing out
to a possible role of Nha1 in cell cycle regulation. The positive
e¡ect of Nha1 was not dependent of its ability to improve
tolerance to Naþ cations, and could not be mimicked by over-
expression of the powerful Naþ-ATPase ENA1 (a major de-
terminant of salt tolerance in S. cerevisiae) or the S. pombe
Sod2 antiporter. Budding yeast Nha1 is a 985 amino acid
protein in which approximately the ¢rst 450 residues corre-
spond to the transmembrane domain, followed by a large
carboxy-terminal tail. By deletion mapping, we were able to
show [18] that a region near the carboxy-terminal end of
Nha1, comprising from residue 800 to 948, was required for
the antiporter to e¡ectively overcome the cell cycle blockage,
and contained residues important to modulate the transport
of potassium. Here we extend these ¢ndings and present a
detailed mutational analysis of this important region of
Nha1 that reveals a number of residues necessary for Nha1
function in cell cycle.
0014-5793 / 03 / $22.00 J 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00557-X
*Corresponding author. Fax: (34)-93-5812006.
E-mail address: joaquin.arino@uab.es (J. Arin‹o).
FEBS 27344 4-6-03
FEBS 27344 FEBS Letters 545 (2003) 239^245
2. Materials and methods
2.1. Growth of Escherichia coli and yeast strains
E. coli strains DH5K or DH5 were used as a host for DNA cloning.
Bacterial cells were grown at 37‡C in Luria^Bertani (LB) medium
containing 50 Wg/ml ampicillin for plasmid selection. S. cerevisiae cells
were grown at 28‡C in YPD medium or, when indicated, in complete
minimal (CM) synthetic medium lacking uracil [19]. Strain JC002
(MATa sit4: :TRP1 tetO:HAL3) derives from JA100 [15] and the
salt-hypersensitive strain B31 (MATK ena1v: :HIS3: :ena4v nha1: :
LEU2) derives from W303-1B [9].
2.2. Recombinant DNA techniques and plasmid constructions
E. coli cells were transformed by using standard calcium chloride
treatment [20] or by electroporation [21] when high e⁄ciency was
needed. Yeast cells were transformed following a modi¢cation of de-
scribed methods [22]. Restriction reactions, DNA ligations, and other
standard recombinant DNA techniques were carried out as described
elsewhere [20].
The construction of pES071, which allows high-copy number ex-
pression of a version of NHA1 carrying a C-terminal 3UHA-tag, was
as follows. The 4.3 kbp XbaI/SphI fragment of plasmid VHS5A/Ura
[18], containing the NHA1 gene was cloned into the same sites of
pUC19, yielding pES018. An arti¢cial SalI site right in front of the
stop codon (which introduces the residues VD) was then created by
sequential polymerase chain reaction (PCR) [23], and the ampli¢ca-
tion fragment used to replace the 1.1 kbp ApaI/SphI fragment of
pES018, to yield pES070. A 3UHA-tag, with added SalI sites, was
ampli¢ed by PCR from plasmid pCM113 [24], and cloned in the
appropriate orientation in pES070. The resulting 3UHA-tagged ver-
sion of NHA1 (pES099) was then transferred to plasmid YEplac195
[25] for expression in yeast, producing plasmid pES071.
To generate plasmid pES149, which allows expression of the
S. pombe sod2þ gene under the control of the strong ADH1 promoter,
the BamHI 3.4 kbp fragment from plasmid pDBSod2 [18] was cloned
into the same site of plasmid YEplac195.
A version of Sod2 carrying the carboxy-terminal tail of S. cerevisiae
NHA1 was constructed as follows. The 1.4 kbp intronless sod2þ frag-
ment described in [18] was cloned into the BamHI site of plasmid
pGEM3Z+ (Promega) to produce pES035. A XhoI site was intro-
duced between residues S451 and D452 of Sod2 by sequential PCR,
and the resulting fragment used to replace the original 0.76 kbp
NheI/EcoRI fragment present in pES035. The new construct
(pES116) was digested with BamHI and the approximately 1.4 kbp
fragment, containing the Sod2 open reading frame (ORF) plus the
added XhoI site, cloned into the BglII site of plasmid pDB20BglII
[26] to generate pES121. This construct was digested with BamHI to
release a 3.4 kbp fragment containing the Sod2 ORF (with the added
XhoI site) £anked by the ADH1 promoter and terminator elements,
which was cloned into the BamHI site of YEplac195, to yield pES134.
The carboxy-terminal half of NHA1 (from N458 to the stop codon,
including the 3UHA-tag at its 3P-end), was ampli¢ed from pES071 by
PCR, with added XhoI sites. The 1.7 kbp ampli¢cation fragment was
cloned into pBS-SK (Stratagene), sequenced, released by XhoI diges-
tion and cloned into the arti¢cial XhoI site of plasmid pES134 in the
appropriate orientation to produce plasmid pES136. Therefore, this
construct bears a fusion of S. pombe Sod2 and the C-terminal half of
S. cerevisiae Nha1, carrying a triple HA-tagging, under the control of
the ADH1 transcriptional promoter.
All PCR-produced fragments were fully sequenced using an ABI
3100 Genetic Analyzer (Applied Biosystems) and the big dye 3.0 ter-
minator kit, to detect unwanted changes in sequence and/or verify the
desired mutations.
2.3. Mutagenesis of the carboxy-terminal half of Nha1
Internal deletions were generated by sequential PCR as follows. The
VHS5A/Ura genomic clone [18] was used as template and the ampli-
¢ed fragments, once its sequence was veri¢ed, used to replace the
equivalent ones in pES018. In the case of the deletion between resi-
dues 800 and 849 (inclusive), a 1.98 kbp HpaI/SphI fragment contain-
ing the desired deletion was ampli¢ed and used to replace the original
fragment. Deletions between residues 900^925 and 926^954 were
made by removing the 1.06 kbp ApaI/SphI region and replacing it
with PCR-ampli¢ed DNA fragments containing the indicated dele-
tions. In all cases, the entire XbaI/SphI fragment, containing the modi-
¢ed versions of the antiporter, was recovered from pES018 and cloned
back into YEplac195 for high-copy expression in yeast.
To generate a library of clones containing the NHA1 ORF enriched
for mutations at the 775^980 region, we proceeded as follows. A 1.65
kbp fragment was ampli¢ed by sequential PCR so that a SpeI restric-
tion site was introduced at position +2298 from the initiating ATG
codon (the changes introduced did not modify the amino acid se-
quence). Then, a 1.26 HpaI/ApaI fragment, including the arti¢cial
SpeI site, was used to replace the equivalent fragment of plasmid
pES070. The resulting construct (pES153) was digested with XbaI/
SphI and the 4.3 kbp insert was cloned into the same sites of YE-
plac195 (pES154). pES153 was used as a template to amplify a 0.68
kbp fragment, spanning from the SpeI to the SalI arti¢cial sites in-
troduced in the NHA1 ORF, in four independent reactions, as de-
scribed in [27] with some modi¢cations. The four reaction products
were mixed, puri¢ed, digested with SpeI and SalI, and used to replace
the equivalent 0.66 kbp fragment by ligation into the SpeI/SalI sites of
pES154. The ligation products were then introduced into E. coli com-
petent cells by electroporation. Plasmid DNA from at least 30 000
independent clones was recovered, ampli¢ed, and the library used
for the Nha1 loss-of-function screening.
2.4. Screening for loss of function of Nha1 in cell cycle
Strain JC002 (sit4: :TRP1 tetO:HAL3) was transformed with the
above-mentioned library (approximately 30 000 clones) and plated in
CM plates lacking uracil. After 48 h, colonies (200^1000/plate) were
replicated on CM (lacking uracil) plates containing 20 Wg/ml doxycy-
cline and these plates were incubated for 48^72 h. Clones unable to
grow in the presence of doxycycline were picked out from the master
plates, and the plasmids recovered in E. coli and tested for integrity of
the insert by restriction mapping. The constructs were then reintro-
duced into strain JC002 (and tested again for loss of growth in the
presence of doxycycline), as well as into strain B31 (and tested for
growth in high sodium). Clones negative for growth in doxycycline
were subjected to DNA sequencing, covering the entire SpeI/SalI 0.66
kbp fragment subjected to mutagenesis, to identify possible mutations
responsible for the loss of function. In some cases, when two di¡erent
mutations were encountered in this region and they were separated by
the ApaI site (residues 866^867), it was possible to evaluate the e¡ect
of the mutation downstream this restriction site by rescuing the 1.06
kbp ApaI/SphI fragment of the mutated clone and using it to replace
the equivalent region of pES153. Then, the 4.3 kbp XbaI/SphI insert
was cloned into the same sites of YEplac195 and the existence of a
single mutation con¢rmed by DNA sequencing.
2.5. Other techniques
Immunoelectrophoretic analysis was performed as follows. JC002
cells carrying the di¡erent constructs were grown up to an OD660 of
approximately 2, collected by centrifugation, and disrupted by vortex-
ing with the aid of glass beads in the presence of a bu¡er containing
100 mM Tris^HCl (pH 7.5), 150 mM NaCl, 1 mM ethylenediamine
tetraacetic acid (EDTA), 1 mM dithiothreitol (DTT), plus an anti-
protease mixture (0.5 mM phenylmethylsulfonyl £uoride, 1 Wg/ml leu-
peptin, 0.5 mM benzamidine, 1 Wg/ml pepstatin). The mixture was
centrifuged at 750Ug for 10 min at 4‡C to remove glass beads and
cellular debris, and the supernatant recovered (total cell extract). 50 Wl
of this extract was centrifuged at 16 100Ug for 15 min at 4‡C, the
supernatant was recovered (16 K supernatant), and the pellet resus-
pended in the same volume of the disruption bu¡er described above
(16 K pellet). Samples (40 Wg of protein) were subjected to sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) (8%
acrylamide) and proteins were transferred to Immobilon-P mem-
branes (Millipore), blocked, and incubated with a monoclonal anti-
HA antibody (Roche). Immunoreactive proteins were identi¢ed with
luminescence substrates (ECL, Amersham).
Growth on plates (drop tests) was assessed as described in [28].
Tolerance to cations was determined in liquid cultures as described
[29].
3. Results
In a recent paper [18], we demonstrated that high levels of
expression of the S. cerevisiae Nha1 antiporter were able to
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relieve G1/S cell cycle blockage, while overexpression of the
S. pombe homolog Sod2, which lacks a carboxy-terminal tail,
was not. As it was also found that Nha1 required its carboxy-
terminal half to carry out this function, we considered the
possibility that the failure observed for Sod2 could be due
to the absence of the necessary carboxy-terminal tail. To
test this possibility, we constructed a fusion protein compris-
ing the ¢rst 451 residues of S. pombe Sod2 (transmembrane
domain) followed by the last 528 residues of Nha1 (that is,
starting shortly after the last transmembrane domain of Nha1,
where the sequence similarity between both proteins is lost).
This construct also contained a triple HA carboxy-terminal
tag, to allow immunological detection of the expressed pro-
tein. As shown in Fig. 1A, the tagged version of Nha1 re-
tained its ability to allow growth of the JC002 strain
(although perhaps with somewhat less potency). This version
of Nha1 was fully functional in terms of providing high-so-
dium tolerance to a B31 strain, but slightly less e¡ective than
the non-tagged protein in allowing growth in high potassium.
As documented previously, overexpression of Sod2 did not
recover growth of a sit4 tetO:HAL3 strain (JC002) on non-
permissive conditions (that is, in the presence of doxycycline),
nor increased tolerance to high potassium. Interestingly, the
Sod2 version carrying the carboxy-terminal tail of Nha1 also
failed to promote growth when subjected to these tests. It is
important to note that the hybrid protein was successfully
expressed, as deduced from the observation that B31 cells
containing this construct showed a very high tolerance to
sodium ions. Furthermore, immunological analysis (Fig. 1B)
showed that most of the expressed protein was recovered in
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Fig. 1. Functional analysis of a chimerical Sod2/Nha1 protein. A: Upper panel: Strain JC002 was transformed with plasmids YEplac195
(YEp), VHS5A/Ura (NHA1), pES071 (NHA1-3HA), pES149 (SOD2) or pES136 (SOD2-NHA1-3HA). 3 Wl of a diluted suspension of cells
(OD660 0.03) were spotted on CM plates lacking uracil in the absence (3) or the presence (+) of 20 Wg/ml doxycycline (Dox). Growth was
monitored after 3 days. Lower panel: The above-mentioned plasmids were introduced into strain B31 and diluted cell suspensions (OD660
0.015) grown for 15 h on YPD (pH 5.5), in the presence of 0.4 M sodium chloride (closed bars) or 1 M potassium chloride (empty bars). Rela-
tive growth was calculated as the ratio between growth in the presence and growth in the absence of the added salt, and represented as per-
centage. Data are meansWS.E.M. from three to six independent clones. B: Total cells extracts were obtained from strain JC002 bearing the in-
dicated plasmids, and 16 K pellets and supernatants were prepared as indicated in Section 2. Samples (40 Wg of protein) were electrophoresed,
transferred to membranes and probed with monoclonal anti-HA antibodies to detect the expressed tagged proteins.
Fig. 2. Functional mapping of the Nha1 antiporter by selective dele-
tions within its 800^954 carboxy-terminal region. Upper panel:
Strain JC002 (sit4: :TRP1 tetO:HAL3) was transformed with high-
copy plasmid YEplac195 (YEp), as well as with the same plasmid
bearing the native NHA1 gene (VHS5A/Ura) or di¡erent NHA1 ver-
sions in which the indicated regions had been deleted, and tested
for growth as described in Fig. 1. Growth was monitored after
3 days. Lower panel: Strain B31 (ena1v: :HIS3: :ena4v nha1: :
LEU2) was transformed with the indicated constructs and the cells
tested for growth as indicated in Fig. 1. Data are meansWS.E.M.
from three independent clones.
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particulate fractions, as expected from a protein associated to
membranes.
Our previous work revealed that a region spanning from
residues 800 to 948 of the presumably cytoplasmic carboxy-
terminal half of Nha1 was necessary for function in cell cycle.
To gain more insight on the structural elements involved in
this e¡ect, we prepared versions of Nha1 carrying di¡erent
deletions within this region. As shown in Fig. 2, when these
versions were tested on strain JC002 under non-permissive
conditions, none of the versions was able to allow growth.
In contrast, when introduced into the salt-hypersensitive
strain B31 (ena1-ena4v nha1), all of them conferred a toler-
ance to high concentrations of sodium chloride similarly to
that produced by a native version of the antiporter. Interest-
ingly, all three mutated versions were less e¡ective than the
native NHA1 clone in supporting growth in liquid cultures
containing 1 M potassium chloride. This growth defect was
not due to an osmotic e¡ect, as growth in the presence of 2 M
sorbitol was essentially identical in all cases (not shown).
The observation that structural elements important for cell
cycle-related function were located in di¡erent segments of the
region spanning from residues 800 to 954 of Nha1 prompted
us to undertake a detailed mutagenesis analysis of this region
using a random mutagenesis PCR approach. Functional anal-
ysis of about 30 000 clones yielded 121 candidate clones, un-
able to allow growth of JC002 cells. However, in many cases
failure to growth was due to deletions (45 clones) or insertions
(one clone) that would change the reading frame. In addition,
eight clones contained premature stop codons, de¢ning six
di¡erent stop positions at codons 788, 797, 811, 822, 827
and 890. All these versions were tested for growth in high
potassium, sodium and lithium. It could be observed that
the version carrying a stop codon at position 890 was the
only one conferring a slightly improved tolerance to sodium
and a very strong tolerance to lithium to B31 cells (data not
shown).
The ¢nal output of this screening was the identi¢cation of
18 single point mutations that would block the ability of
Nha1 to allow growth of JC002 cells in the presence of doxy-
cycline. As it can be observed (Fig. 3, upper panel), most
mutations cluster into two regions. The ¢rst region (cluster A)
spans from S869 to T876 and contains four mutations. Two of
the changes (L870F and T874A) resulted in partial loss of
function, as they allowed growth of the JC002 strain, albeit
rather slow. On the contrary, mutation T876A completely
blocked growth of strain JC002, even after 7 days of incuba-
Fig. 3. Localization and phenotypic e¡ects of point mutations impairing the function of Nha1 in cell cycle. Upper panel: Strain JC002 was
transformed with YEplac195 (YEp), plasmid VHS5A/Ura (NHA1) or the same high-copy plasmid bearing versions of the Nha1 antiporter car-
rying the indicated point mutations. Growth was monitored after 4 days. The approximate location of each mutation within the region 775^
980 is depicted on the top, including location of clusters A and B (see main text). Lower panel: Strain B31 was transformed with the above-
mentioned plasmids and tolerance to sodium tested on CM plates (lacking uracil) in the absence or the presence of 0.5 M NaCl. Growth was
monitored after 4 days. In all cases strains were spotted in a single plate for each condition tested and are aligned in the ¢gure for descriptive
purposes. The same strains were grown in liquid YPD medium (pH 5.5) in the presence or absence of 20 mM LiCl. Relative growth was calcu-
lated as the ratio between growth in the presence and growth in the absence of the added salt, and represented as percentage. Data are means
WS.E.M. from four experiments.
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tion (when normally this strain recovers somewhat from the
e¡ect of doxycycline). The second region (cluster B) includes
amino acids 918^927 and in this short segment, composed of
10 residues, mutations for all but two of them (E921 and Q925)
have been found. Several of these mutations had a very severe
e¡ect on growth, similarly to that of the T876A change, while
one mutation (T920A) still allowed growth on doxycycline,
although very slowly. In addition, a pair of close mutations,
a¡ecting residues R834 and L836, has been identi¢ed. Four
additional changes resulting in loss of function were found
upstream (I798N and S817P), or downstream (G932S and
E943K) of the mentioned groups.
All mutated versions of Nha1 were also tested for the abil-
ity to confer tolerance to high potassium, sodium or lithium
to strain B31. We observed that most mutations in cluster B
slightly reduced cell growth in the presence of high concen-
trations of potassium chloride, similarly to that observed for
the versions carrying deletions (data not shown). When toler-
ance to sodium cations was tested, we found (Fig. 3, lower
panel) that with the exception of the L836S and M869V
changes, mutations on the residues of cluster A produced a
slight decrease in tolerance to sodium. Mutations in cluster B
yielded a non-homogeneous phenotype: while some of them,
such as T920A and R924G, conferred higher tolerance than
native Nha1, a conserved change, R926K, resulted in a rather
strong decrease in the ability of this Nha1 version to improve
tolerance to sodium cations. The evaluation of lithium toler-
ance in strains overexpressing the mutated forms of Nha1
yielded rather interesting results. At low LiCl concentrations
(10 mM), di¡erences in tolerance were small (not shown).
However, when higher concentrations were tested (20 mM),
at which overexpression of wild-type Nha1 cannot signi¢-
cantly improve growth, we found that mutations at positions
798 and 817, and particularly all mutations in cluster B (but
none in cluster A) were able to strongly improve growth. The
only exception was the conserved change R926K, which did
not improve tolerance and, in fact, when tested at lower LiCl
concentrations, resulted in slightly lower tolerance than that
conferred by wild-type Nha1.
4. Discussion
In contrast to what is known for certain fungi, such as
S. pombe or Z. rouxii, in which Naþ/Hþ antiporters are major
elements for sodium and lithium cation tolerance [3,30], in the
budding yeast S. cerevisiae the Naþ/Hþ antiporter Nha1 rep-
resents a relatively minor component of the mechanisms in-
volved in tolerance to sodium cations. Alternatively, other
cellular roles, such as regulation of cell volume, Kþ concen-
tration or intracellular pH have been proposed for this protein
[9^11].
Recently, we showed that Nha1 might be involved in the
regulation of cell cycle progression, as high-copy expression of
this gene (from its own promoter) was able to rescue the G1/S
cell cycle blockage of a conditional sit4 hal3 mutant [18]. This
ability was not related to the capacity of the antiporter to
increase tolerance to sodium cations, but required the pres-
ence of the transmembrane antiporter region and the integrity
of a relatively large region of its carboxy-terminal tail, com-
prising approximately from residue 800 to 948. The require-
ment for this carboxy-terminal element was indicative that it
might be important for regulation of the Nha1 function in cell
cycle. Therefore, we undertake its functional characterization
aiming to get further insight into the regulation and function
of this protein.
We show here that expression of a chimera in which the
transmembrane region of Nha1 has been replaced by the
equivalent (43% of identity, 58% conserved residues) element
of the S. pombe antiporter Sod2 is able to increase tolerance
to sodium cations, even more e⁄ciently than that native Nha1
does. While this might re£ect the highest transport capacity of
the Sod2 antiporter, as previously demonstrated [31], in our
case it may just result from a di¡erent expression level, some-
what higher in the case of Sod2 (it should be noted that the
promoter elements in both constructs were not equivalent).
The hybrid protein was not able to allow growth at high
potassium, suggesting that the inability of S. pombe Sod2 to
transport potassium [31] is an intrinsic property of the trans-
membrane domain and not due to the lack of a carboxy-ter-
minal moiety. In any case, this hybrid protein failed to sustain
growth of strain JC002 under non-permissive conditions, in-
dicating that while the 800^948 carboxy-terminal region of
Nha1 is required for function in cell cycle, speci¢c elements
at the amino-terminal transmembrane region, not present in
Sod2, must be also important.
A more detailed analysis of the carboxy-terminal region was
initiated by generating several deletions within the region 800^
954 (Fig. 2). All of them resulted in loss of the suppressor
e¡ect when these versions of Nha1 were tested in JC002 cells,
indicating that residues important for this function are dis-
persed within this relatively large region. These deletions
also resulted in a small, but signi¢cant reduction in the growth
rate of the cells at high potassium, suggesting the alterations
in this region of the protein may a¡ect the capacity for po-
tassium transport. This agrees with our previous ¢ndings [18],
although it must be noted that other authors have reported
that high-copy expression of versions of Nha1 carrying trun-
cation of most of its carboxy-terminal tail still support growth
on high potassium [32]. This apparent discrepancy may result
from the fact that we determine the e¡ect of high potassium in
liquid culture, which allows a more sensitive monitoring of
growth.
The possibility that residues important for cell cycle func-
tion could be dispersed within the 800^954 region prompted
us to develop a strategy to identify point mutations within this
segment of the protein that could abolish the ability of Nha1
to rescue growth of JC002-blocked cells. Among the muta-
tions identi¢ed, six corresponded to premature stop codons,
at positions 788, 797, 811, 822, 827 and 890, thus con¢rming
our previous ¢nding in that truncations prior residue 923
eliminate the function [18]. In addition, the version truncated
at position 890 was able to increase tolerance of B31 cells,
moderately to sodium and strongly to lithium cations. This is
in agreement with the previous ¢nding that the original ge-
nomic clone isolated, which was truncated at position 888,
was more e⁄cient in increasing the tolerance to these cations
than the entire protein [6,9].
In addition, 18 single additional mutations resulting in
change of amino acid were identi¢ed. These mutations were
located between residues 798 and 943, and a¡ected all three
short segments deleted within the 800^954 region, thus ex-
plaining the phenotype previously observed (Fig. 2). However,
it is remarkable that most mutations (12 out of 18) clustered
into two very short regions (clusters A and B, Figs. 3 and 4),
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suggesting that these regions are particularly important in
function. Cluster B corresponds to a short region highly con-
served between most fungal antiporters (Fig. 4), de¢ned as C6
in [8], while cluster A contains a non-conserved sequence,
speci¢c for S. cerevisiae. This probably explains why the
C. albicans antiporter Cnh1, which does not contain a similar
sequence, was unable to replace Nha1 [18] despite their overall
similarity (54% of identity). In addition, we have identi¢ed
mutations, such as L870F, T874A or T920A with relatively
weak e¡ect on cell cycle, while others (for instance, most
mutations in cluster B) appear to aggravate the growth defect,
resulting in a dominant negative phenotype. This would be
compatible with the notion of this region acting as a regula-
tory one.
The availability of these mutations allowed us to evaluate
their e¡ect on the ability of the antiporter to increase toler-
ance to alkaline cations. Perhaps the most interesting ¢nding
is the observation that 11 out of 18 mutations strongly in-
crease tolerance to lithium cations. Two aspects are remark-
able: (1) the position of the mutated residues is not random,
as none of the six mutations from residues 834 to 876 results
in increased tolerance, and (2) all mutations in cluster B, with
the only exception of the R926K change, improve lithium
tolerance. It is reasonable to assume that the lack of positive
e¡ect of this mutation is due to the conservative nature of the
change, although it must be noted that a similar change in the
following position (R927K) does improve tolerance. In fact,
with this only exception, all mutations from position 918 to
the carboxy-terminal end of Nha1 result in increased lithium
tolerance, suggesting that this region of the protein contains a
negative element for lithium transport. The observation that
Nha1 versions truncated at positions 888 and 890 also in-
crease lithium tolerance ([9] and this work) suggests that
this negative element might extend at least 20 residues up-
stream in the protein sequence. It should be noted that the
relevance of residues 920^928 in Nha1 with respect to lithium
tolerance has been pointed out in a recent report [32], showing
that truncation at residues 920, 923 and 928 resulted in in-
creased tolerance to lithium. Therefore, our data con¢rm and
expand these results, by showing that residues at positions
817, 834, 932 and 943 also play an important role in regulat-
ing the ability of Nha1 to extrude lithium.
The identi¢cation of sequences important for Nha1 to play
a role in cell cycle (as well as in saline homeostasis) reinforces
the notion that a possible role for the carboxy-terminal tail of
Nha1 would be to regulate speci¢c functions of this antiport-
er. It is worth noting that we do not observe here a correla-
tion between cell cycle and saline phenotypes, supporting the
idea that both are probably unrelated events. In mammalian
cells, the carboxy-terminal tail of Naþ/Hþ exchangers has
been identi¢ed as target for regulation (see [33] for review),
including phosphorylation by di¡erent protein kinases. It is
suggestive that ¢ve of the mutated residues identi¢ed in this
work correspond to Ser or Thr residues that are located in a
favorable context [34] for phosphorylation by casein kinase-2
(S817, S918 and T920), cAMP-dependent protein kinase (T874)
or calcium-calmodulin kinase II (T876). In addition, at least in
the case of mammalian NHE3, the existence of interacting
proteins (named NHERFs, for Naþ=Hþ exchanger regulatory
factors) that can serve as adapters for speci¢c protein^protein
interactions has been demonstrated. It is suggestive that, while
in the overall the carboxy-terminal tail sequence of Nha1 does
not display evident sequence similarity with other proteins, a
structural element quite similar to the conserved cluster B in
Nha1 (Fig. 4B) can be found at the carboxy-terminal end of
one of the variants of the regulatory factor NHERF2 (TKA1/
E3KARP, accession number Z50150). The possibility of this
element playing a regulatory role is being investigated in our
laboratory.
We have recently carried out a two-hybrid approach using
the carboxy-terminal tail of Nha1 as bait to search for pro-
teins able to interact with this region, which yielded no detect-
A) 
                       *                      *                   * *  
ScNha1 787..KYHAFKIDNLLIIE----NEDGDVIKRYKINPHKSD.....SKNRPRNDS-VVSRALTAVGLKSKANSGV....849 
HaNha1 728..KYTAYKLDNQLVIE----NEDGEIIRRYKINHHKTT.....-RSRASTMAGGIGKALSAVGIKSSLGESP....789 
CtNha1 777..KVYAHRVDNLIVIE----NEDGEIIRRYKVNKHTPD.....SKSRSRSSS-LMGMVKSIVGKKSGDTPSP....848 
CaCnh1 658..KVYAHRVDDLIVIE----NEDGDIIRRYKVNKHAPA.....---RARSGS-IMGMVKSMVGIKPPPEISV....715 
PfNha1 730..LVYAHRVDNFIFIE----NADGEIIRRYRVNPHTKA.....DKSNQGINS-VFNKAISLVGIKNKPKADE....791 
AnNha1 807..QEFADQIRNLGPKARQSIVEDSDAPKRVKDAARDDA.....SAHQTGAPHDDLESVSSGSDDEPDSEEGP....885 
  
                              **   * *                                         *  ** *** **    *          *  
ScNha1 854..DEEKAIEGPSRKGP---GMLKKRTLTPAPPRGVQDSLDLEDEPSSE....DSYNMDDSEDYDDNAYES--ETEFERQRRLNALGEMTAPADQDDEELP..946 
HaNha1 793..AVDHLALEPIQQPE---HPEDEDVDS-EEEEDSELEEQSQEEDDSE....DDDEVEDSEGEEQGGIDDVEETEVERARRLTALGQFAAPRDEEDEEEG..887 
CtNha1 862..DLEQGNSSRILLPHREVNEEDEHMDS-RMEHKLEDKLANILEHKHE....DDEEEEESDWSQDSEAE--EETEVEKRRRLQALGKLPTSHNKDDEEEV  975 
CaCnh1 717..DLEHGTQHKIILPE----EENTPMSS-KTEQKLEDTIANILQENHT....---------ISEESADE--EETEVEKKRRLQALGYLPSSRRDREDEEE  796 
PfNha1 799..DLEKNNQNVLVPEHDEEDNNNHPLKDPKIESKIENKLTNLILNSSN....DDNEADTGAASMDSEDEDLHETEVERKRRLAALGHMPTKRDVNDEEE-  926 
AnNha1 895..RIAAGTATGTAADERRKDLSPGTSSRERSPRSRRDSDDDGTERVPP....------LALPQQALDLDDTGETPAERRRRLAALGEYSDSEDDVDSDAV..990 
                             ----------          ------------- 
                             CLUSTER A            CLUSTER B 
 
 
B) 
 
ScNha1        898..DLGDSYNMDDSEDYDDNAYESETEFERQRRLNALGEMTAPADQDDEELPPLPVEAQTGNDGPGTAE..963 
TKA1/E3KARP   392..GTGGLWQQDRGRETQRCERESETETERERERHRE-------RQRESERARGSRGARAFAALPGPAD..450 
Fig. 4. Comparative analysis of residues important for Nha1 cell cycle function in other yeast antiporter sequences. A: The complete amino
acid sequences of the Naþ/Hþ antiporters from S. cerevisiae (ScNha1, GenBank, DDBJ accession number Z73310), Hansenula anomala (Ha-
Nha1, AB073976), Candida tropicalis (CtNha1, AB073975), C. albicans (CaCnh1, AF375984), Pichia farinosa (PfNha1, AJ496431) and Aspergi-
lus nidulans (AnNha1, AB073977) were aligned using Clustal W (version 1.8). The regions corresponding to the mutagenized segment of S. ce-
revisiae Nha1 are represented. Very poorly conserved regions, not comprising point mutations described in this paper (showed as asterisks),
have been eliminated and are represented by several dots. Conserved residues are denoted by black-shaded boxed, while conservative changes
are shaded in gray. B: Alignment (Clustal W 1.8) of the region surrounding cluster B in S. cerevisiae Nha1 and the carboxy-terminal end of
isoform 3 of human TKA1/E3KARP (GenBank, DDBJ Z50150).
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able interactions. However, very recently, a di¡erent approach
based on a⁄nity precipitation and mass spectrometry analysis
has revealed a possible interaction between Nha1 and the
product of the YHL010c ORF [35]. This gene encodes a
585-residue protein of unknown function, which is remarkably
similar (31% identity, 47% conserved residues) to BRAP2, a
human protein able to bind to nuclear localization signal mo-
tifs [36] found in BRCA1, a breast cancer susceptibility gene
product that contributes to homologous recombination, DNA
repair and transcriptional regulation [37]. A data bank survey
reveals that YHL010c may contain several interesting struc-
tural domains, such as a RING ¢nger domain (C3HC4-type),
a Zn ¢nger found in ubiquitin hydrolases and other proteins,
and an ERM-like binding domain. These structural elements
are known in many cases to mediate protein^protein interac-
tions, often involved in signal transduction and cell prolifer-
ation. Therefore, it would be most interesting to investigate if
the Nha1 residues essential for cell cycle function identi¢ed in
this work are involved in binding and/or signalling through
YHL010C.
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